Charles Berkman, general counsel for Ligand Pharmaceuticals, left, and Hayden Trubitt, a shareholder in Stradling’s corporate practice group, right.
“Lawyers, in my personal view and to over-generalize, can be a little too risk-averse,” said Charles Berkman, longtime general counsel Ligand Pharmaceuticals Inc., a San Diego-based firm that licenses and supplies Captisol, a crucial ingredient in experimental COVID-19 treatment drug remdesivir.
May 15, 2020 at 01:36 PM
1 minute read
The original version of this story was published on Corporate Counsel
Being flexible while having a healthy appetite for risk appears to be paying off for Ligand Pharmaceuticals Inc., a San Diego-based firm that licenses and supplies Captisol, a crucial ingredient in experimental COVID-19 treatment drug remdesivir.
“Lawyers, in my personal view and to over-generalize, can be a little too risk-averse,” said Ligand’s longtime general counsel, Charles Berkman.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
